These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9142180)

  • 1. Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study.
    Takanami I; Tanaka F; Hashizume T; Kodaira S
    J Surg Oncol; 1997 Apr; 64(4):262-7. PubMed ID: 9142180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR; Schreiber SL
    Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.
    Takanami I; Imamura T; Hashizume T; Kikuchi K; Yamamoto Y; Kodaira S
    J Clin Pathol; 1994 Dec; 47(12):1098-100. PubMed ID: 7876382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
    Wikström P; Bergh A; Damber JE
    Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome.
    Chung HL; Hwang JB; Park JJ; Kim SG
    J Allergy Clin Immunol; 2002 Jan; 109(1):150-4. PubMed ID: 11799382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling.
    Blobe GC; Schiemann WP; Pepin MC; Beauchemin M; Moustakas A; Lodish HF; O'Connor-McCourt MD
    J Biol Chem; 2001 Jul; 276(27):24627-37. PubMed ID: 11323414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
    Guo Y; Jacobs SC; Kyprianou N
    Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the immunodetection of transforming growth factor-beta in lung adenocarcinoma and longer survival rates.
    Inoue T; Ishida T; Takenoyama M; Sugio K; Sugimachi K
    Surg Oncol; 1995 Feb; 4(1):51-7. PubMed ID: 7780613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.
    Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G
    Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis.
    Leivo T; Leivo I; Kariniemi AL; Keski-Oja J; Virtanen I
    Br J Dermatol; 1998 Jan; 138(1):57-62. PubMed ID: 9536223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
    Doré JJ; Edens M; Garamszegi N; Leof EB
    J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts.
    Mori Y; Hatamochi A; Arakawa M; Ueki H
    Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study of transforming growth factor-beta and central fibrosis in T1 adenocarcinoma of the lung].
    Asakura S; Kato H; Fujino S; Konishi T; Asada Y; Tezuka N; Mori A
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Dec; 43(12):1924-8. PubMed ID: 8551073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta isoforms expressions in pulmonary adenocarcinomas as prognostic markers: an immunohistological study of one hundred and twenty patients.
    Takanami I; Tanaka F; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
    Oncology; 1997; 54(2):122-8. PubMed ID: 9075783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.
    Jiang W; Yang CQ; Liu WB; Wang YQ; He BM; Wang JY
    World J Gastroenterol; 2004 Jun; 10(11):1634-8. PubMed ID: 15162539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.